[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 57, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 325000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deina H. Walsh", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 212500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shun'ichi  Kuroda", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.36, "open": 2.23, "dayLow": 2.22, "dayHigh": 2.4, "regularMarketPreviousClose": 2.36, "regularMarketOpen": 2.23, "regularMarketDayLow": 2.22, "regularMarketDayHigh": 2.4, "beta": 0.586, "forwardPE": -0.07414766, "volume": 43882, "regularMarketVolume": 43882, "averageVolume": 285756, "averageVolume10days": 311270, "averageDailyVolume10Day": 311270, "bidSize": 1800, "askSize": 2900, "marketCap": 2057359, "fiftyTwoWeekLow": 2.2, "fiftyTwoWeekHigh": 86.88, "fiftyDayAverage": 3.66438, "twoHundredDayAverage": 9.161425, "currency": "USD", "enterpriseValue": -1776398, "floatShares": 486247, "sharesOutstanding": 879176, "sharesShort": 17215, "sharesShortPriorMonth": 42317, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0322, "heldPercentInsiders": 0.04892, "heldPercentInstitutions": 0.017, "shortRatio": 0.32, "shortPercentOfFloat": 0.0343, "bookValue": 5.44, "priceToBook": 0.43016544, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -8948731, "trailingEps": -34.01, "forwardEps": -31.56, "lastSplitFactor": "1:2", "lastSplitDate": 1634083200, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BBLG", "underlyingSymbol": "BBLG", "shortName": "Bone Biologics Corp", "longName": "Bone Biologics Corporation", "firstTradeDateEpochUtc": 1634131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ef723e6d-c4c0-3645-8eff-e1206a869bb4", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.3401, "targetHighPrice": 19.5, "targetLowPrice": 19.5, "targetMeanPrice": 19.5, "targetMedianPrice": 19.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 3026569, "totalCashPerShare": 5.665, "quickRatio": 3.64, "currentRatio": 4.496, "returnOnAssets": -0.96341, "returnOnEquity": -2.02147, "freeCashflow": -7210886, "operatingCashflow": -9555904, "financialCurrency": "USD", "trailingPegRatio": null}]